Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington, involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Corixa Corporation, United States, covering academic research published from 2000 to 2014. Read More.
Open Access Percentage
55%
Total
Publications
207
Total Open
Publications
113
Total
Citations
18K
Open Access
Percentage
55%
Total
Publications
207
Total Open
Publications
113
Total
Citations
18K
Breakdown
Publisher Open
29%
Both
9%
Other Platform Open
17%
Closed
45%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 4%
3
Hybrid 6%
5
No Guarantees 90%
70
Other Platform Open
Domain 93%
50
Institution 11%
6
Public 6%
3
Preprint 0%
0
Other Internet 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 49 |
Europe PMC | Domain | 45 |
Semantic Scholar | Public | 3 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Institution | 3 |
Queen's University Belfast - Research Portal | Institution | 2 |
University of Michigan - Deep Blue | Institution | 1 |